This Diabetes Company’s Q1 Earnings Reflect the Resiliency of Its Business Model
This Diabetes Company's Q1 Earnings Reflect the Resiliency of Its Business Model 1The COVID-19 pandemic is presenting a headwind, but Insulet’s recurring-revenue-generating business model helps insulate it.
News story posted on 2020-06-01T02:12:00.0000000Z